BioLight Life Valuation
| BOLT Stock | ILS 350.00 10.00 2.78% |
At this time, the firm appears to be overvalued. BioLight Life Sciences shows a prevailing Real Value of S332.2 per share. The current price of the firm is S350.0. Our model approximates the value of BioLight Life Sciences from analyzing the firm fundamentals such as Shares Owned By Insiders of 56.36 %, return on equity of -0.0911, and Current Valuation of 13.59 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that BioLight Life's price fluctuation is very steady at this time. Calculation of the real value of BioLight Life Sciences is based on 3 months time horizon. Increasing BioLight Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for BioLight Life Sciences is useful when determining the fair value of the BioLight stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of BioLight Life. Since BioLight Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioLight Stock. However, BioLight Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 350.0 | Real 332.2 | Hype 350.0 | Naive 331.41 |
The real value of BioLight Stock, also known as its intrinsic value, is the underlying worth of BioLight Life Sciences Company, which is reflected in its stock price. It is based on BioLight Life's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of BioLight Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioLight Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioLight Life Sciences helps investors to forecast how BioLight stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioLight Life more accurately as focusing exclusively on BioLight Life's fundamentals will not take into account other important factors: BioLight Life Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining BioLight Life's current stock value. Our valuation model uses many indicators to compare BioLight Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioLight Life competition to find correlations between indicators driving BioLight Life's intrinsic value. More Info.BioLight Life Sciences is number one stock in price to earning category among related companies. It is number one stock in price to book category among related companies fabricating about 0.01 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for BioLight Life Sciences is roughly 134.11 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioLight Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioLight Life's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioLight Life's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BioLight Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BioLight Life and how it compares across the competition.
About BioLight Life Valuation
The stock valuation mechanism determines the current worth of BioLight Life Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of BioLight Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of BioLight Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing BioLight Life's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of BioLight Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioLight Life. We calculate exposure to BioLight Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BioLight Life's related companies.BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.
8 Steps to conduct BioLight Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioLight Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioLight Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioLight Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioLight Life's revenue streams: Identify BioLight Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioLight Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioLight Life's growth potential: Evaluate BioLight Life's management, business model, and growth potential.
- Determine BioLight Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioLight Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLight Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for BioLight Stock analysis
When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |